ITI (ITCI) Posts Quarterly Earnings Results, Beats Estimates By $0.08 EPS
ITI (NASDAQ:ITCI) posted its quarterly earnings results on Tuesday. The company reported ($0.15) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.23) by $0.08, American Banking News.com reports.
Shares of ITI (NASDAQ:ITCI) opened at 15.88 on Tuesday. ITI has a 52-week low of $13.26 and a 52-week high of $21.264. The stock’s 50-day moving average is $15.51 and its 200-day moving average is $16.77. The company’s market cap is $464.1 million.
Intra-Cellular Therapies Inc is a United States-based biopharmaceutical company. The Company is developing drugs for the treatment of diseases and disorders of the Central Nervous System (NASDAQ:ITCI).
Receive News & Ratings for ITI Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ITI Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.